All Items of Business Approved
TSX | NYSE: ACB
EDMONTON, Dec. 4, 2018 /PRNewswire/ - Aurora Cannabis
Inc. (the "Company" or "Aurora" or the "Issuer") (NYSE: ACB) (TSX:
ACB) (Frankfurt: 21P; WKN: A1C4WM)
today announced the voting results from its Annual General and
Special Meeting of Shareholders (the "Meeting"), held in
Edmonton, Alberta, on November 30, 2018. The total number of shares
represented by shareholders present in person and by proxy at the
meeting was 384.4 million representing 39.9% of Aurora's issued and
outstanding Common Shares.
All of the matters put forward before shareholders for
consideration and approval as set out in the Company's Management
Information Circular dated October 16,
2018, were approved by the requisite majority of votes cast
at the Meeting. The details of the voting results for the election
of directors are set out below:
Nominee
|
# Votes
for
|
% Votes
for
|
Terry
Booth
|
126,784,380
|
83.79%
|
Steve
Dobler
|
108,463,649
|
71.68%
|
Jason Dyck
|
123,845,475
|
81.84%
|
Adam
Szweras
|
146,398,326
|
96.75%
|
Michael
Singer
|
119,259,971
|
78.81%
|
Diane Jang
|
144,986,982
|
95.81%
|
Norma
Beauchamp
|
144,867,860
|
95.74%
|
Ronald
Funk
|
145,803,917
|
96.35%
|
The shareholders also approved the: (i) appointment of KPMG LLP
as auditors of the Company for the ensuing year; (ii) non-binding
advisory vote on the Company's approach to executive compensation;
(iii) the Company's Deferred Share Unit Plan; (iv) the Company's
Shareholder Rights Plan; and (v) the adoption of the
Company's new Business Corporations Act (British Columbia) Articles.
The Company has filed a report of voting results on all
resolutions voted on at the Meeting on www.sedar.com.
Long-Term Incentive Awards
The Company granted a total of 140,000 options to purchase
common shares of Aurora to independent directors of the Company.
These options vest annually over 36 months and are exercisable at
$7.51 per common share. Additionally,
the Company granted a total of 24,000 deferred stock units to
independent directors of the Company, vesting quarterly over 12
months.
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 500,000 kg per
annum and sales and operations in 21 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high quality product at low cost. Intended to be replicable and
scalable globally, our production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and low per gram production costs. Each of
Aurora's facilities is built to meet EU GMP standards, and its
first production facility, the recently acquired MedReleaf Markham
facility, and its wholly owned European medical cannabis
distributor Aurora Deutschland, have achieved this level of
certification.
In addition to Aurora's rapid organic growth and strong
execution on strategic M&A, which to date includes 15 wholly
owned subsidiary companies – MedReleaf, CanvasRX, Peloton
Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator,
BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela,
and ICC – Aurora is distinguished by its reputation as a partner
and employer of choice in the global cannabis sector, having
invested in and established strategic partnerships with a range of
leading innovators, including: Radient Technologies Inc. (TSXV:
RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd.
(ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom
Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty
Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC:
CTTH), and Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and are a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com
Neither the TSX, NYSE nor their Regulation Services
Provider (as that term is defined in the policies of the TSX and
NYSE) accepts responsibility for the adequacy or accuracy of this
release.
Terry Booth, CEO
Aurora Cannabis Inc.
Forward-Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur and include, but are not limited to the
variety of cannabis products that Aurora will supply to the adult
use market.. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-announces-2018-agm-voting-results-300759918.html
SOURCE Aurora Cannabis Inc.